Home Data Calendar Blog

CSTL

Tables

    2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31
Weighted Average Number Of Diluted Shares Outstanding 27.48NA26.8326.7326.61NA26.3226.0625.42NA25.2925.0924.91NA19.9417.5418.73NA14.301.771.57NA1.57NANA
Weighted Average Number Of Shares Outstanding Basic 27.48NA26.8326.7326.61NA26.3226.0625.42NA25.2925.0924.91NA19.9417.5417.37NA12.761.771.57NA1.57NANA
Earnings Per Share Basic -0.09-0.09-0.26-0.70-1.10-0.79-0.77-0.06-0.97-0.25-0.47-0.35-0.17-0.23-0.23-0.080.030.120.43-1.28-1.491.82-2.84-2.62-2.89
Earnings Per Share Diluted -0.09-0.09-0.26-0.70-1.10-0.79-0.77-0.06-0.97-0.25-0.47-0.35-0.17-0.23-0.23-0.080.030.110.05-1.28-1.490.46-2.84-2.62-2.89

    2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31
Revenue From Contract With Customer Excluding Assessed Tax 72.9766.1261.4950.1442.0438.3437.0134.8426.8525.0423.4822.7622.8117.3015.2212.7117.4217.6414.7710.748.7211.443.713.983.66
Revenues 72.9766.1261.4950.1442.0438.3437.0134.8426.8525.0423.4822.7622.8117.3015.2212.7117.4217.6414.7710.748.7211.443.713.983.66
Cost Of Revenue 13.8912.4211.3211.0610.189.528.867.695.944.604.503.703.032.672.482.152.392.011.711.991.601.371.351.33NA
Cost Of Goods And Services Sold 13.8912.4211.3211.0610.189.528.867.695.944.604.503.703.032.672.482.152.392.011.711.991.601.371.351.33NA
Research And Development Expense 13.8112.9912.9213.3114.3911.3110.9111.9310.769.457.506.795.914.583.062.702.913.161.511.321.391.141.291.16NA
Selling General And Administrative Expense 48.4944.0944.6244.6846.7638.4336.6337.5030.4525.1622.5920.8218.1614.9611.7010.3911.089.857.126.826.054.173.924.16NA
Operating Income Loss -5.47-5.66-9.64-21.16-31.52-22.83-21.54-3.97-24.52-15.17-11.81-8.81-4.28-3.03-3.90-0.651.042.614.430.61-0.324.77-2.85-2.67NA
Interest Expense 0.010.000.000.000.000.000.010.000.00NANANANA0.400.710.770.760.771.091.691.020.650.570.52NA
Interest Expense Long Term Debt 0.01NANANANANANANANANANANANANANANANANANANANANANANANA
Allocated Share Based Compensation Expense 12.6811.8013.0412.8513.539.929.208.788.426.855.214.774.912.962.121.651.580.710.230.140.170.070.070.08NA
Income Tax Expense Benefit 0.040.040.030.020.010.060.00-1.960.13-8.720.000.01NANANA0.000.000.070.000.000.000.010.000.00NA
Net Income Loss -2.53-2.58-6.91-18.78-29.20-20.62-20.25-1.65-24.62-6.43-11.79-8.79-4.28-4.89-4.59-1.380.572.065.85-1.27-1.363.87-3.45-3.15-3.63
Comprehensive Income Net Of Tax -2.78-2.37-6.83-18.79-28.96-20.81-20.44-1.65-24.62-6.43-11.79-8.79-4.28-4.89-4.59-1.380.572.055.85-1.27-1.363.87-3.45-3.15NA

    2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31
Assets 458.51453.34436.02425.40426.89447.33457.81458.38444.43462.57433.69435.53437.33439.33210.39201.55120.26119.75113.2033.35NA22.40NANANA
Liabilities 56.0562.0750.2446.6341.7448.1846.3836.7247.0950.8321.9819.6218.7523.6443.8443.9232.3234.6330.8636.94NA32.47NANANA
Liabilities And Stockholders Equity 458.51453.34436.02425.40426.89447.33457.81458.38444.43462.57433.69435.53437.33439.33210.39201.55120.26119.75113.2033.35NA22.40NANANA
Stockholders Equity 402.46391.27385.78378.77385.15399.15411.43421.66397.34411.74411.71415.92418.59415.69166.56157.6287.9385.1182.34-50.20-49.43-56.57-60.45-57.05-53.93

    2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31
Assets Current 295.78295.63279.62269.05271.10292.29299.41304.91336.44353.74389.58391.70426.67429.59201.06195.67116.55116.68109.8628.52NA18.13NANANA
Cash And Cash Equivalents At Carrying Value 82.9598.8491.2295.87114.82122.95134.18273.17309.02329.63363.18368.34406.98409.85183.05179.7698.6598.8494.5017.50NA4.48NANANA
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 82.9598.8491.2295.87114.82122.95134.18273.17309.02329.63363.18368.34406.98409.85183.05179.7698.6598.8494.4717.4716.234.483.285.21NA
Accounts Receivable Net Current 42.7038.3037.0031.3127.7323.4822.8422.6119.9117.2818.5317.8214.2912.7612.6212.5314.6014.6512.379.73NA12.09NANANA
Inventory Net 7.647.945.776.124.523.983.803.372.352.022.382.122.312.221.681.671.221.240.820.55NA0.88NANANA
Prepaid Expense And Other Assets Current 6.226.297.106.116.806.216.795.785.164.815.503.423.094.773.721.722.081.952.200.77NA0.68NANANA
Available For Sale Securities Debt Securities 156.26144.26138.53129.63117.23135.68131.80NANANANANANANANANANANANANANANANANANA

    2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31
Amortization Of Intangible Assets 2.252.272.272.252.222.212.312.101.651.010.690.26NANANA0.000.00-0.000.000.000.000.010.010.01NA
Goodwill 10.7010.7010.7010.7010.7010.6910.4910.49NANANANANANANANANANANANANANANANANA
Finite Lived Intangible Assets Net 104.40106.64108.92111.19113.43115.66119.87122.1887.2888.9232.1032.80NANANANANA0.000.000.00NA0.00NANANA
Intangible Assets Net Including Goodwill 115.09117.33119.61121.88124.13126.35130.36132.67NA88.92NANANANANANANANANANANANANANANA
Other Assets Noncurrent 1.721.441.571.190.791.111.201.222.701.721.731.631.761.541.640.200.220.140.091.81NA0.21NANANA
Available For Sale Debt Securities Amortized Cost Basis 156.37144.12138.60129.78117.37136.06131.99NANANANANANANANANANANANANANANANANANA

    2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31
Liabilities Current 31.9647.6736.3233.7230.1436.1331.9427.5239.5224.8920.9918.6517.5820.8830.2428.2415.2615.299.2411.75NA6.74NANANA
Accounts Payable Current 9.3210.276.937.139.964.735.773.283.312.552.771.372.172.102.102.501.931.861.252.08NA1.45NANANA
Other Accrued Liabilities Current 6.747.325.907.325.615.265.118.185.595.683.112.522.023.063.442.751.851.810.981.62NA0.72NANANA

    2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31
Long Term Debt 10.00NANANANANANANANANANANANANANANANA26.69NANANANANANANA
Long Term Debt Noncurrent 10.00NANANANANANANANANANANANANA12.4614.7417.0119.2921.5723.86NA24.50NANANA
Deferred Income Tax Liabilities Net 0.210.210.440.440.440.430.610.610.760.64NANANANANANANANANANANANANANANA
Other Liabilities Noncurrent 0.020.030.040.050.060.090.120.160.100.12NANANA1.03NANANANANANANANANANANA
Operating Lease Liability Noncurrent 13.8614.1713.4412.4311.1011.5311.906.486.716.90NANANANANANANANANANANANANANANA

    2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31
Stockholders Equity 402.46391.27385.78378.77385.15399.15411.43421.66397.34411.74411.71415.92418.59415.69166.56157.6287.9385.1182.34-50.20-49.43-56.57-60.45-57.05-53.93
Additional Paid In Capital 623.45609.48601.62587.77575.37560.41551.88541.67515.70505.48499.05491.46485.34478.16224.15210.62139.56137.31136.599.91NA0.92NANANA
Retained Earnings Accumulated Deficit -220.91-218.37-215.79-208.89-190.11-160.91-140.29-120.04-118.39-93.77-87.36-75.57-66.78-62.50-57.61-53.02-51.64-52.20-54.27-60.12NA-57.49NANANA
Accumulated Other Comprehensive Income Loss Net Of Tax -0.110.14-0.07-0.14-0.14-0.38-0.19NANANANANANANANANANANANANANANANANANA

    2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31
Net Cash Provided By Used In Operating Activities -6.8318.595.01-3.79-25.44-6.00-5.22-9.00-21.43-2.78-6.13-6.44-3.63-0.43-2.9613.50-0.254.490.750.481.29-3.21-1.88NANA
Net Cash Provided By Used In Investing Activities -19.70-7.67-9.71-15.3916.58-4.48-134.15-27.51-0.40-30.89-0.92-34.09-0.75-0.59-1.90-1.76-0.50-0.35-0.17-0.18-0.24-0.01-0.09NANA
Net Cash Provided By Used In Financing Activities 10.64-3.300.040.230.73-0.750.390.661.220.131.891.891.51227.828.1569.360.560.2276.420.9410.714.420.04NANA

    2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31
Net Cash Provided By Used In Operating Activities -6.8318.595.01-3.79-25.44-6.00-5.22-9.00-21.43-2.78-6.13-6.44-3.63-0.43-2.9613.50-0.254.490.750.481.29-3.21-1.88NANA
Net Income Loss -2.53-2.58-6.91-18.78-29.20-20.62-20.25-1.65-24.62-6.43-11.79-8.79-4.28-4.89-4.59-1.380.572.065.85-1.27-1.363.87-3.45-3.15-3.63
Depreciation Depletion And Amortization 3.343.223.173.042.892.842.922.632.151.451.090.630.230.160.12NANANANANANANANANANA
Increase Decrease In Accounts Receivable 4.261.155.803.604.380.540.052.902.73-1.460.813.721.560.190.48-2.18-0.161.702.820.22-3.847.750.03NANA
Increase Decrease In Inventories -0.302.17-0.351.600.540.180.440.740.33-0.350.25-0.320.090.540.010.45-0.020.420.27-0.26-0.070.57-0.10NANA
Increase Decrease In Accounts Payable -0.423.01-0.38-0.823.90-1.571.850.120.19-0.851.36-0.64-0.04-0.04-0.230.390.060.600.48-0.20-0.330.370.44NANA
Deferred Income Tax Expense Benefit NA-0.240.000.000.01-0.040.00-1.960.12NANANANANANANANANANANANANANANANA
Share Based Compensation 12.6811.8013.0412.8513.539.929.208.788.426.855.214.774.912.962.121.651.580.710.230.140.170.070.07NANA

    2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31
Net Cash Provided By Used In Investing Activities -19.70-7.67-9.71-15.3916.58-4.48-134.15-27.51-0.40-30.89-0.92-34.09-0.75-0.59-1.90-1.76-0.50-0.35-0.17-0.18-0.24-0.01-0.09NANA
Payments To Acquire Property Plant And Equipment 9.153.792.464.043.341.792.041.410.400.890.930.910.750.591.911.760.500.350.170.180.240.010.09NANA

    2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31
Net Cash Provided By Used In Financing Activities 10.64-3.300.040.230.73-0.750.390.661.220.131.891.891.51227.828.1569.360.560.2276.420.9410.714.420.04NANA

    2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31
Revenues 72.9766.1261.4950.1442.0438.3437.0134.8426.8525.0423.4822.7622.8117.3015.2212.7117.4217.6414.7710.748.7211.443.713.983.66
Dermatologic 59.3353.2851.1543.0335.9134.6533.9231.9024.3422.8721.5920.3820.91NANANANANANANANANANANANA
Non Dermatologic 13.6412.8410.347.116.133.693.092.942.51NANANANANANANANANANANANANANANANA
Revenue From Contract With Customer Excluding Assessed Tax 72.9766.1261.4950.1442.0438.3437.0134.8426.8525.0423.4822.7622.8117.3015.2212.7117.4217.6414.7710.748.7211.443.713.983.66
Dermatologic 59.3353.2851.1543.0335.9134.6533.9231.9024.3422.8721.5920.3820.91NANANANANANANANANANANANA
Non Dermatologic 13.6412.8410.347.116.133.693.092.942.51NANANANANANANANANANANANANANANANA

Plots across concepts


IncomeStatement
Operating Income Loss
Expenses
Interest Expense
Balance Sheet
Long Term Debt
Assets
Inventory Net
Current Assets
Prepaid Expense And Other Assets Current
NonCurrent Assets
Other Assets Noncurrent
Liabilities
Operating Lease Liability
Current Liabilities
Operating Lease Liability Current
Noncurrent Liabilities
Other Liabilities Noncurrent
Stockholders Equity
Retained Earnings Accumulated Deficit
CashFlow
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInOperatingActivities
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInInvestingActivities
Net Cash Provided By Used In Investing Activities
Shares
Weighted Average Number Of Diluted Shares Outstanding
OperatingLeaseLiability
Operating Lease Liability Current
LesseeOperatingLeaseLiabilityPaymentsDue
Lessee Operating Lease Liability Payments Due Year Three
FiniteLivedIntangibleAssets
Finite Lived Intangible Assets Accumulated Amortization

Line plots across dimensions of each concept